Floatz logo

Therapeutic Asset Ratings

5,108 results matching 1 filter

91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
MERCAPTOPURINE ANHYDROUS
T-Lymphoblastic Lymphoma
Children's Oncology GroupP3BB (66)
Mesna
Diffuse Large B-Cell Lymphoma
The First Affiliated Hospital with Nanjing Medical UniversityP3BB (66)
Metformin
Asthma
Prof Ibrahim JanahiP3BB (66)
Metformin
Fanconi Anemia
Ain Shams UniversityP3BB (66)
METHOTREXATE
Acute Myeloid Leukemia
Children's Oncology GroupP3BB (66)
METHOTREXATE
T-Cell Adult Acute Lymphocytic Leukemia
National Cancer Institute (NCI)P3BB (66)
METHOTREXATE
Breast Cancer
University of Illinois at ChicagoP3BB (66)
METHOTREXATE
Intraocular Lymphoma
Aldeyra Therapeutics, Inc.P3BB (66)
Mitoxantrone
Myelodysplastic Syndrome
Fred Hutchinson Cancer CenterP3BB (66)
Mitoxantrone
Prostate Cancer
Shanghai Jiao Tong University School of MedicineP3BB (66)
mt-1186
Amyotrophic Lateral Sclerosis
Tanabe Pharma CorporationP3BB (66)
Muamycin
Anal Carcinoma
Federation Francophone de Cancerologie DigestiveP3BB (66)
Multiple Vitamins Injection
Basal Cell Carcinoma
Women's College HospitalP3BB (66)
Multiple Vitamins Injection
Squamous Cell Carcinoma
Women's College HospitalP3BB (66)
Navacaprant
Major Depressive Disorder
Neumora Therapeutics, Inc.P3BB (66)
NEPENTHE
Cancer-Related Condition
Instituto Nacional de Cancer, BrazilP3BB (66)
Nerandomilast
Idiopathic Pulmonary Fibrosis
Boehringer IngelheimP3BB (66)
NEUROTOP
Tuberous Sclerosis
GRIN Therapeutics, Inc.P3BB (66)
Nivestim
Hodgkins Lymphoma
Thomas Jefferson UniversityP3BB (66)
Nivolumab
Skin Cancer
7 Hills Pharma, LLCP3BB (66)
NOGITECAN
Fallopian Tube Cancer
Sichuan Baili Pharmaceutical Co., Ltd.P3BB (66)
NOGITECAN
Fallopian Tube Serous Adenocarcinoma
National Cancer Institute (NCI)P3BB (66)
NOGITECAN
Lung Cancer
Fox Chase Cancer CenterP3BB (66)
NOGITECAN
Ovarian Cancer
GenmabP3BB (66)
Nrtx-1001
Temporal Lobe Epilepsy
Neurona TherapeuticsP3BB (66)
Showing 1251 to 1275 of 5,108 assets
PreviousPage 51 of 205Next